Position in GH
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$2,979,579
+$2,198,106 QoQ
Shares Held
32,257
+321.6% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Edgestream Partners, L.P. holds $7,616,279 across 5 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
10,841 | $2,458,630 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
1,863 | $2,380,001 | |
| 3 | LH |
Labcorp Holdings Inc.
|
5,885 | $1,647,800 | |
| 4 | TWST |
Twist Bioscience Corp
|
5,992 | $616,456 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
1,024 | $513,392 |
All Filings in GH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,979,579 | 32,257 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $781,473 | 7,651 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,411,728 | 38,600 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,629,008 | 50,519 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $870,105 | 20,425 | Shares | Sole | 2025-05-02 | |
| 2024-06-30 | $2,787,295 | 96,513 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $968,351 | 46,939 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $266,550 | 9,854 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||